Polymorphism rs1057147 located in mesothelin gene predicts lymph node metastasis in patients with gastric cancer.
Cancer prognosis
Gastric cancer
Gene polymorphism
Genomic alteration
Lymph node metastasis
Journal
Applied microbiology and biotechnology
ISSN: 1432-0614
Titre abrégé: Appl Microbiol Biotechnol
Pays: Germany
ID NLM: 8406612
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
07
02
2023
accepted:
22
04
2023
revised:
18
04
2023
medline:
15
5
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
ppublish
Résumé
Lymph node metastasis, a crucial factor in the spread of gastric cancer (GC), is strongly associated with a negative prognosis for patients. This study aimed to investigate the association of the mesothelin (MSLN) gene polymorphisms (rs3764247, rs3764246, rs12597489, rs1057147, and rs3765319) with the risk of lymph node metastasis of GC patients in a Chinese Han population. The PCR-LDR genotyping was used to detect the genotypes of MSLN polymorphisms in GC patients with lymph node metastasis (n = 610) or without (n = 356). Our research indicates that certain genetic markers, specifically rs3764247, rs3764246, rs12597489, and rs3765319, do not appear to be linked with an increased risk of lymph node metastasis in GC. However, we did observe that patients with the rs1057147 GA genotype exhibited a higher likelihood of lymph node metastasis in GC when compared to those with the GG genotype (OR = 1.33, 95% CI = 1.01 - 1.76, P = 0.045). Patients with rs1057147 GA + AA genotype were found to have a higher likelihood of lymph node involvement (OR = 1.35, 95% CI = 1.03 - 1.77, P = 0.029) when compared to those with GG genotype in the dominant model. The allelic model revealed that the A allele of rs1057147 exhibited a stronger correlation with lymph node metastasis compared to the G allele (OR = 1.28, 95% CI = 1.02 - 1.60, P = 0.031). In addition, we found that rs1057147 polymorphism revealed a poor prognosis for GC patients with lymph node metastasis. Further stratified analysis revealed that the prognostic effect of rs1057147 was more pronounced in patients with GC who had lymph node metastasis and had a tumor size of 4 cm or greater, as well as more than 2 lymph node metastases. Bioinformatics studies showed that the binding mode of miR-3144-5p or miR-3619-3p to MSLN was altered by the mutation of rs1057147. Our study confirmed the important role of MSLN rs1057147 polymorphism locus in GC lymph node metastases and suggested a potential prognostic factor during GC progression. KEY POINTS: • Rs1057147 GA genotype had an increased risk of lymph node metastasis in gastric cancer. • The A allele of rs1057147 had a stronger association with lymph node metastasis than the G allele. • The binding mode of miR-3144-5p or miR-3619-3p to MSLN was altered by the mutation of rs1057147.
Identifiants
pubmed: 37145159
doi: 10.1007/s00253-023-12555-8
pii: 10.1007/s00253-023-12555-8
doi:
Substances chimiques
Mesothelin
J27WDC343N
MicroRNAs
0
MIRN-3619 microRNA, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3637-3651Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Abou-El-Naga AM, Abo El-Khair SM, Mahmoud AZ, Hamza M, Elshazli RM (2021) Association of genetic variants in the 3′-untranslated region of the mesothelin (MSLN) gene with ovarian carcinoma. J Biochem Mol Toxicol 35(2):e22637. https://doi.org/10.1002/jbt.22637
doi: 10.1002/jbt.22637
pubmed: 32997381
Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ (2020) Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci 21(5) https://doi.org/10.3390/ijms21051723
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A (2013) NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res 41(D1):D991-5. https://doi.org/10.1093/nar/gks1193
doi: 10.1093/nar/gks1193
pubmed: 23193258
Boffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LN (2020) Survival after cancer treatment at top-ranked US cancer hospitals vs affiliates of top-ranked cancer hospitals. JAMA Netw Open 3(5):e203942. https://doi.org/10.1001/jamanetworkopen.2020.3942
doi: 10.1001/jamanetworkopen.2020.3942
pubmed: 32453382
pmcid: 7251445
Bosch F, Todorova R, Link H, Westphalen CB, Boeck S, Heinemann V, Werner J, Kirchner T, Angele MK, Neumann J (2019) Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases. J Cancer Res Clin Oncol 145(11):2689–2697. https://doi.org/10.1007/s00432-019-03029-4
doi: 10.1007/s00432-019-03029-4
pubmed: 31541339
Cai F, Dong Y, Wang P, Zhang L, Yang Y, Liu Y, Wang X, Zhang R, Liang H, Sun Y, Deng J (2022) Risk assessment of lymph node metastasis in early gastric cancer: establishment and validation of a seven-point scoring model. Surgery 171(5):1273–1280. https://doi.org/10.1016/j.surg.2021.10.049
doi: 10.1016/j.surg.2021.10.049
pubmed: 34865863
Carlborg O, Haley CS (2004) Epistasis: too often neglected in complex trait studies? Nat Rev Genet 5(8):618–625. https://doi.org/10.1038/nrg1407
doi: 10.1038/nrg1407
pubmed: 15266344
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China. CA Cancer J Clin 66(2):115–132. https://doi.org/10.3322/caac.21338
Dai CL, Yang ZG, Xue LP, Li YM (2013) Application value of multi-slice spiral computed tomography for imaging determination of metastatic lymph nodes of gastric cancer. World J Gastroenterol 19(34):5732–5737. https://doi.org/10.3748/wjg.v19.i34.5732
doi: 10.3748/wjg.v19.i34.5732
pubmed: 24039369
pmcid: 3769913
de Almeida RC, Chagas VS, Castro MAA, Petzl-Erler ML (2018) Integrative analysis identifies genetic variants associated with autoimmune diseases affecting putative microRNA binding sites. Front Genet 9:139. https://doi.org/10.3389/fgene.2018.00139
doi: 10.3389/fgene.2018.00139
pubmed: 29755505
pmcid: 5932181
Deng N, Zhou H, Fan H, Yuan Y (2017) Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8(66):110635–110649. https://doi.org/10.18632/oncotarget.22372
doi: 10.18632/oncotarget.22372
pubmed: 29299175
pmcid: 5746410
Di J, Ji H, Ji F, Zhao J, Zhang C, Tang H, Li E, Cao H, Jiang B (2021) Current status and development trends of morbidity and mortality in gastric cancer patients in Xining, 2009–2016. Am J Transl Res 13(11):12431–12439
pubmed: 34956464
pmcid: 8661187
Fang X, Wei J, He X, An P, Wang H, Jiang L, Shao D, Liang H, Li Y, Wang F, Min J (2015) Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer 51(18):2820–2832. https://doi.org/10.1016/j.ejca.2015.09.010
doi: 10.1016/j.ejca.2015.09.010
pubmed: 26589974
Fang T, Zhang L, Yin X, Wang Y, Zhang X, Bian X, Jiang X, Yang S, Xue Y (2023) The prognostic marker elastin correlates with epithelial-mesenchymal transition and vimentin-positive fibroblasts in gastric cancer. J Pathol Clin Res 9(1):56–72. https://doi.org/10.1002/cjp2.298
doi: 10.1002/cjp2.298
pubmed: 36226731
Garritano S, De Santi C, Silvestri R, Melaiu O, Cipollini M, Barone E, Lucchi M, Barale R, Mutti L, Gemignani F, Bonotti A, Foddis R, Cristaudo A, Landi S (2014) A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people. J Thorac Oncol 9(11):1662–1668. https://doi.org/10.1097/JTO.0000000000000322
doi: 10.1097/JTO.0000000000000322
pubmed: 25436799
Ge Y, He Y, Jiang M, Luo D, Huan X, Wang W, Zhang D, Yang L, Zhou J (2017) Polymorphisms in lncRNA PTENP1 and the risk of gastric cancer in a Chinese population. Dis Markers 2017:6807452. https://doi.org/10.1155/2017/6807452
doi: 10.1155/2017/6807452
pubmed: 28931965
pmcid: 5592395
Giordano G, Ferioli E, Tafuni A (2022) The role of mesothelin expression in serous ovarian carcinoma: impacts on diagnosis, prognosis, and therapeutic targets. Cancers (Basel) 14(9) https://doi.org/10.3390/cancers14092283
Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, Zhu J, Haussler D (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38(6):675–678. https://doi.org/10.1038/s41587-020-0546-8
doi: 10.1038/s41587-020-0546-8
pubmed: 32444850
pmcid: 7386072
Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V, Franko A (2020) Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases. Radiol Oncol 54(1):86–95. https://doi.org/10.2478/raon-2020-0011
doi: 10.2478/raon-2020-0011
pubmed: 32187018
pmcid: 7087423
He C, Tu H, Sun L, Xu Q, Gong Y, Jing J, Dong N, Yuan Y (2015) SNP interactions of Helicobacter pylori-related host genes PGC, PTPN11, IL1B, and TLR4 in susceptibility to gastric carcinogenesis. Oncotarget 6(22):19017–26. https://doi.org/10.18632/oncotarget.4231
doi: 10.18632/oncotarget.4231
pubmed: 26158864
pmcid: 4662472
He X, Wang L, Riedel H, Wang K, Yang Y, Dinu CZ, Rojanasakul Y (2017) Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells. Mol Cancer 16(1):63. https://doi.org/10.1186/s12943-017-0633-8
doi: 10.1186/s12943-017-0633-8
pubmed: 28288645
pmcid: 5348784
Hirotsu Y, Hada M, Amemiya K, Oyama T, Mochizuki H, Omata M (2020) Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer. J Gastroenterol 55(5):553–564. https://doi.org/10.1007/s00535-019-01659-6
doi: 10.1007/s00535-019-01659-6
pubmed: 31912238
Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S (2004) Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 25(6):973–978. https://doi.org/10.1093/carcin/bgh080
doi: 10.1093/carcin/bgh080
pubmed: 14729580
Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, Wang Z, Tang H, Qin Y, Guan XY (2022) Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res 41(1):287. https://doi.org/10.1186/s13046-022-02449-4
doi: 10.1186/s13046-022-02449-4
pubmed: 36171622
pmcid: 9520879
Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. CA Cancer J Clin 71(3):264–279. https://doi.org/10.3322/caac.21657
doi: 10.3322/caac.21657
pubmed: 33592120
pmcid: 9927927
Karimzadeh MR, Zarin M, Ehtesham N, Khosravi S, Soosanabadi M, Mosallaei M, Pourdavoud P (2020) MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis. Cancer Gene Ther 27(10–11):739–753. https://doi.org/10.1038/s41417-020-0172-0
doi: 10.1038/s41417-020-0172-0
pubmed: 32203060
Kong X, Yang S, Liu C, Tang H, Chen Y, Zhang X, Zhou Y, Liang G (2020) Relationship between MEG3 gene polymorphism and risk of gastric cancer in Chinese population with high incidence of gastric cancer. Biosci Rep 40(11) 10.1042/BSR20200305
Kozlov AP (2022) The theory of carcino-evo-devo and its non-trivial predictions. Genes (Basel) 13(12) https://doi.org/10.3390/genes13122347
Lee HH, Kim SY, Jung ES, Yoo J, Kim TM (2019) Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases. Gastric Cancer 22(2):323–334. https://doi.org/10.1007/s10120-018-0870-6
doi: 10.1007/s10120-018-0870-6
pubmed: 30132154
Li W, Ye F, Wang D, Sun X, Tong W, Lian G, Jiang J, Suo J, Zhang DY (2013) Protein predictive signatures for lymph node metastasis of gastric cancer. Int J Cancer 132(8):1851–1859. https://doi.org/10.1002/ijc.27864
doi: 10.1002/ijc.27864
pubmed: 23011604
Morgan AD, Seely KD, Hagenstein LD, Florey GM, Small JM (2022) Bacterial Involvement in progression and metastasis of adenocarcinoma of the stomach. Cancers (Basel) 14(19) https://doi.org/10.3390/cancers14194886
Nagata K, Shinto E, Shiraishi T, Yamadera M, Kajiwara Y, Mochizuki S, Okamoto K, Einama T, Kishi Y, Ueno H (2021) Mesothelin expression is correlated with chemoresistance in stage IV colorectal cancer. Ann Surg Oncol 28(13):8579–8586. https://doi.org/10.1245/s10434-021-10507-y
doi: 10.1245/s10434-021-10507-y
pubmed: 34318385
Nguyen NT, Dang NT, Dang QH, Tran VC, Vo HL, Yamaguchi M, Ta TV (2021) Polymorphism of MUC1 gene in vietnamese gastric cancer patients: a multicenter case-control study. Front Oncol 11:694977. https://doi.org/10.3389/fonc.2021.694977
doi: 10.3389/fonc.2021.694977
pubmed: 34532288
pmcid: 8439541
Okholm C, Svendsen LB, Achiam MP (2014) Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review. Surg Oncol 23(3):140–146. https://doi.org/10.1016/j.suronc.2014.06.001
doi: 10.1016/j.suronc.2014.06.001
pubmed: 24953457
Raei N, Behrouz B, Zahri S, Latifi-Navid S (2016) Helicobacter pylori infection and dietary factors act synergistically to promote gastric cancer. Asian Pac J Cancer Prev 17(3):917–921. https://doi.org/10.7314/apjcp.2016.17.3.917
doi: 10.7314/apjcp.2016.17.3.917
pubmed: 27039812
Rocken C, Amallraja A, Halske C, Opasic L, Traulsen A, Behrens HM, Kruger S, Liu A, Haag J, Egberts JH, Rosenstiel P, Meissner T (2021) Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine. Genome Med 13(1):177. https://doi.org/10.1186/s13073-021-00975-y
doi: 10.1186/s13073-021-00975-y
pubmed: 34749812
pmcid: 8576943
Salaspuro M (2012) Interactions of alcohol and tobacco in gastrointestinal cancer. J Gastroenterol Hepatol 27(Suppl 2):135–139. https://doi.org/10.1111/j.1440-1746.2012.07017.x
doi: 10.1111/j.1440-1746.2012.07017.x
pubmed: 22320931
Shen K, Liu K, Wang Y, Ni P, Xiao J, Hao F, Zhou X, Xu Z, Yang L (2022) Polymorphisms of an oncogenic gene, mesothelin, predict the risk and prognosis of gastric cancer in a Chinese Han population. Arch Toxicol 96(7):2097–2111. https://doi.org/10.1007/s00204-022-03290-6
doi: 10.1007/s00204-022-03290-6
pubmed: 35396937
Shi Y, Chen X, Xi B, Yu X, Ouyang J, Han C, Qin Y, Wu D, Shen H (2017) SNP rs3202538 in 3′UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population. Cancer Cell Int 17:81. https://doi.org/10.1186/s12935-017-0449-z
doi: 10.1186/s12935-017-0449-z
pubmed: 28924391
pmcid: 5599891
Shin CM, Park K, Kim N, Won S, Ohn JH, Lee S, Park JH, Kang SJ, Kim JS, Lee DH (2022) rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori-infected individuals: a genome-wide association study in the Korean population. Gastric Cancer 25(3):573–585. https://doi.org/10.1007/s10120-022-01285-x
doi: 10.1007/s10120-022-01285-x
pubmed: 35325318
pmcid: 8943788
Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R (2012) Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 16(1):8–21. https://doi.org/10.1111/j.1582-4934.2011.01359.x
doi: 10.1111/j.1582-4934.2011.01359.x
pubmed: 21692980
Song S, Liu B, Zeng X, Wu Y, Chen H, Wu H, Gu J, Gao X, Ruan Y, Wang H (2022) Reticulon 2 promotes gastric cancer metastasis via activating endoplasmic reticulum Ca(2+) efflux-mediated ERK signalling. Cell Death Dis 13(4):349. https://doi.org/10.1038/s41419-022-04757-1
doi: 10.1038/s41419-022-04757-1
pubmed: 35428758
pmcid: 9012842
Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, Dong W (2020) SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin signaling pathway. Aging 12(4):3574–3593. https://doi.org/10.18632/aging.102831
doi: 10.18632/aging.102831
pubmed: 32091407
pmcid: 7066881
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434–442. https://doi.org/10.1093/jnci/djh075
doi: 10.1093/jnci/djh075
pubmed: 15026468
pmcid: 7713993
Wang M, Yu W, Cao X, Gu H, Huang J, Wu C, Wang L, Sha X, Shen B, Wang T, Yao Y, Zhu W, Huang F (2022) Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming. Front Oncol 12:860175. https://doi.org/10.3389/fonc.2022.860175
doi: 10.3389/fonc.2022.860175
pubmed: 35359362
pmcid: 8960311
Wang H, Gong H, Tang A, Cui Y (2023) Neutrophil/lymphocyte ratio predicts lymph node metastasis in patients with gastric cancer. Am J Transl Res 15(2):1412–1420
pubmed: 36915778
pmcid: 10006780
Xiao J, Zhu C, Ni P, Chen W, Li Z, Fan H, Ma X, Xu Z, Yang L (2021) Correlations of SNHG5 genetic polymorphisms with susceptibility and prognosis to gastric cancer in a Chinese population. Genomics 113(4):1754–1760. https://doi.org/10.1016/j.ygeno.2021.04.025
doi: 10.1016/j.ygeno.2021.04.025
pubmed: 33865958
Xiao J, Shen K, Liu K, Wang Y, Fan H, Cheng Q, Zhou X, Hu L, Wang G, Xu Z, Yang L (2022) Obesity promotes lipid accumulation in lymph node metastasis of gastric cancer: a retrospective case-control study. Lipids Health Dis 21(1):123. https://doi.org/10.1186/s12944-022-01734-7
doi: 10.1186/s12944-022-01734-7
pubmed: 36397145
pmcid: 9673345
Xu Y, Ma H, Yu H, Liu Z, Wang LE, Tan D, Muddasani R, Lu V, Ajani JA, Wang Y, Wei Q (2013) The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer. PLoS One 8(5):e64973. https://doi.org/10.1371/journal.pone.0064973
doi: 10.1371/journal.pone.0064973
pubmed: 23724109
pmcid: 3665554
Yang S, Wang YL, Lyu Y, Jiang Y, Xiang J, Ji S, Kang S, Lyu X, He C, Li P, Liu B, Wu C (2021) mGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancer. Cancer Metab 9(1):34. https://doi.org/10.1186/s40170-021-00269-2
doi: 10.1186/s40170-021-00269-2
pubmed: 34565479
pmcid: 8474935
Yen EY, Miaw SC, Yu JS, Lai IR (2017) Exosomal TGF-beta1 is correlated with lymphatic metastasis of gastric cancers. Am J Cancer Res 7(11):2199–2208
pubmed: 29218244
pmcid: 5714749
Zhang T, Li X, He Y, Wang Y, Shen J, Wang S, You Q, Zhai J, Shen L (2022) Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. Gastric Cancer 25(2):346–359. https://doi.org/10.1007/s10120-021-01259-5
doi: 10.1007/s10120-021-01259-5
pubmed: 34724589
Zhao J, Shi Y, Cao G (2023) The application of single-cell RNA sequencing in the inflammatory tumor microenvironment. Biomolecules 13(2) https://doi.org/10.3390/biom13020344
Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B (2006) Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 27(12):2491–2496. https://doi.org/10.1093/carcin/bgl121
doi: 10.1093/carcin/bgl121
pubmed: 16829688